Exicure (XCUR) to Release Earnings on Wednesday

Exicure (NASDAQ:XCUR) is expected to release its resultson Wednesday, May 13th. Analysts expect Exicure to post earnings of ($18.60) per share and revenue of $1.6440 million for the quarter.

Exicure (NASDAQ:XCUR) last posted its quarterly earnings results on Wednesday, March 25th. The company reported ($0.46) EPS for the quarter, topping analysts’ consensus estimates of ($18.60) by $18.14.

Exicure Stock Performance

Exicure stock opened at $3.38 on Tuesday. Exicure has a 52 week low of $3.10 and a 52 week high of $11.86. The stock has a market capitalization of $21.54 million, a P/E ratio of -4.39 and a beta of 3.62. The stock has a 50-day simple moving average of $3.95 and a 200 day simple moving average of $4.56.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded shares of Exicure to a “hold” rating in a research report on Saturday, January 17th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, Exicure currently has an average rating of “Sell”.

About Exicure

Exicure is a clinical‐stage biotechnology company pioneering the development of next‐generation genetic medicines through its proprietary spherical nucleic acid (SNA) delivery platform. This nanotechnology‐based approach is designed to facilitate the intracellular delivery of oligonucleotide therapeutics, addressing longstanding challenges in targeting hard‐to‐reach tissues such as the central nervous system.

The company’s pipeline encompasses programs for neurological disorders—including Huntington’s disease, Parkinson’s disease and Alzheimer’s disease—as well as exploratory efforts in dermatological indications and oncology.